Human OBCAM/OPCML Antibody, R&D Systems™

OBCAM/OPCML

Polyclonal

Unconjugated

Q14982

OPCML

Mouse myeloma cell line NS0-derived recombinant human OBCAM/OPCML Gly28-Asn322 Accession # Q14982

100 μg

Primary

Detects human OBCAM/OPCML in direct ELISAs and Western blots. In direct ELISAs, less than 5% cross-reactivity with recombinant human (rh) KILON is observed and less than 1% cross-reactivity with rhLAMP is observed.

Human

IgG

Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF

LYOPH

Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, Immunocytochemistry 5-15 ug/mL, CyTOF-ready

IgLON family member 1, IGLON1opioid-binding protein/cell adhesion molecule-like, OBCAMopiate binding-cell adhesion molecule, OPCM, OPCML, opioid binding protein/cell adhesion molecule-like, opioid binding protein/cell adhesion molecule-like preprotein, Opioid-binding cell adhesion molecule, opioid-binding protein/cell adhesion molecule

Goat

Affinity Purified

RUO

4978

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.